title: Modelling Survival in the Presence of Different Mechanisms of Action: Ipilimumab and Vemurafenib in Advanced Melanoma.
authors.affiliation: BresMed, Sheffield, UK.
authors.forename: D
authors.initials: D
authors.lastname: Lee
authors.affiliation: BresMed, Sheffield, UK.
authors.forename: J
authors.initials: J
authors.lastname: Porter
authors.affiliation: Bristol Myers Squibb, Uxbridge, UK.
authors.forename: N
authors.initials: N
authors.lastname: Hertel
authors.affiliation: BresMed, Sheffield, UK.
authors.forename: A J
authors.initials: AJ
authors.lastname: Hatswell